Asian Myeloproliferative Neoplasm (MPN) Registry - An Asian Myeloid Working Group (AMWG) Project.
Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY
This is a multinational, multicenter, prospective and retrospective, observational, cohort study of patients with myeloproliferative neoplasm.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Age ≥ 18 years old at the time of diagnosis of MPN.
• Subject was diagnosed with one of the following disorders according to the 2017 WHO classification (for patients diagnosed before 2017, the bone marrow reports will be re-evaluated according to the 2017 WHO classification):
‣ Polycythaemia vera
⁃ Essential thrombocythemia
⁃ Primary myelofibrosis, pre-fibrotic/early stage
⁃ Primary myelofibrosis, overt fibrotic stage
⁃ Post-polycythaemia vera myelofibrosis
⁃ Post-essential thrombocythaemia myelofibrosis
⁃ MPN-unclassifiable
• All subjects need to provide informed consent.
Locations
Other Locations
Hong Kong Special Administrative Region
Department of Medicine, Queen Mary Hospital
RECRUITING
Hong Kong
Contact Information
Primary
Harinder Gill, MD
gillhsh@hku.hk
+852 22554542
Time Frame
Start Date: 2023-05
Estimated Completion Date: 2026-12
Participants
Target number of participants: 1000
Related Therapeutic Areas
Sponsors
Leads: The University of Hong Kong
Collaborators: Novartis